skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Nutritional benefits of flavocoxid in patients with osteoarthritis: efficacy and safety

Review

(1824) Views  (1077) Full article downloads

Authors: Robert M Levy, Lakshmi Pillai, Bruce P Burnett

Published Date May 2010 Volume 2010:2 Pages 27 - 38
DOI: http://dx.doi.org/10.2147/NDS.S6410

Robert M Levy1, Lakshmi Pillai2, Bruce P Burnett2

1Department of Clinical Development, 2Department of Medical Education and Scientific Affairs, Primus Pharmaceuticals, Inc., Scottsdale, AZ, USA

Abstract: Osteoarthritis (OA) is a major age-related, chronic disease in the United States that results in significant morbidity and functional loss as well as substantial financial outlay. Dietary habits have been shown to influence the metabolic and inflammatory processes involved in OA. For example, a lower intake of antioxidants is associated with increased incidence of OA while an increased intake of flavonoids and omega-3 polyunsaturated acids decreases production of inflammatory mediators and the incidence of OA. These observations argue that dietary habits contribute to the metabolic and inflammatory etiology of chronic diseases such as OA. Flavocoxid is a botanically-based formula composed of concentrated and standardized flavonoids from the botanicals Scutellaria baicalensis and Acacia catechu. Flavonoids constitute a large class of compounds known as polyphenols, ubiquitous in plants and consumed regularly in the human diet. Flavocoxid was developed by extensive high throughput screening and enzymatic testing and two specific flavonoids, catechin and baicalin, were identified that possess potent anti-inflammatory properties. Flavocoxid acts by managing both the cyclooxygenase and 5-lipoxygenase pathways of arachidonic acid metabolism thought to underlie the pathological processes of OA. Preclinical and clinical evidence suggests that flavocoxid provides effective and safe dietary management of the underlying metabolic processes of OA.

Keywords: cyclooxygenase, 5-lipoxygenase, inflammation, flavonoids








Readers of this article also read:

Safety and efficacy of rosiglitazone in the elderly diabetic patient
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Clinical evidence supporting the use of an activated clinoptilolite suspension as an agent to increase urinary excretion of toxic heavy metals
Polyphenols as dietary supplements: A double-edged sword
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Nutritional supplementation to prevent and slow the progression of chronic kidney disease: focus on bicarbonate
Role of green tea in reduction of cardiovascular risk factors
Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University